论文部分内容阅读
颅内动脉瘤在脑血管疾病中属于较常见的一种类型,是神经外科的棘手病症[1],主要因颅内动脉血管异常、动脉血管壁发生病变损伤而引起,在生理结构上表现为动脉血管壁的弥散性或局限性扩张[2]。颅内动脉瘤有破裂危险,一旦破裂出血患者病情危重,致死率和致残率较高[3]。因此,临床提倡早期进行动脉瘤治疗,而临床施治的原则是预防动脉瘤再次破裂出血,以降低不良结局的发生率[4]。现阶段临床治疗颅内动脉瘤
Intracranial aneurysms are one of the more common types of cerebrovascular disease and are a neurological thorny disorder [1], mainly due to intracranial arterial vascular abnormalities and lesions of the arterial wall caused by lesions in the physiological structure of Disseminated or localized arterial wall dilatation [2]. Intracranial aneurysms have a risk of rupture, once the ruptured bleeding patients in critical condition, mortality and morbidity higher [3]. Therefore, the clinical advocate of early aneurysm treatment, and the principle of clinical treatment is to prevent aneurysm rupture again to reduce the incidence of adverse outcomes [4]. Clinical treatment of intracranial aneurysms at this stage